tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

ACET Stock Latest News

Adicet Bio’s Innovative CAR γδ T Cell Therapies: A Promising Buy Rating Amidst Upcoming Phase 1 Data and Market Positioning
RatingsAdicet Bio’s Innovative CAR γδ T Cell Therapies: A Promising Buy Rating Amidst Upcoming Phase 1 Data and Market Positioning
13d ago
ACET
Buy Recommendation for Adicet Bio’s ADI-001: Promising Potential in Autoimmune Disease Treatment
PremiumRatings
Buy Recommendation for Adicet Bio’s ADI-001: Promising Potential in Autoimmune Disease Treatment
18d ago
ACET
Promising Pipeline and Strong Financials Drive Buy Rating for Adicet Bio
PremiumRatings
Promising Pipeline and Strong Financials Drive Buy Rating for Adicet Bio
21d ago
ACET
Adicet Bio Advances Clinical Trials and Financial Stability
PremiumCompany Announcements
Adicet Bio Advances Clinical Trials and Financial Stability
23d ago
ACET
Cautious Hold Rating on Adicet Bio Amid Early-Stage Clinical Developments and Uncertain Outcomes
PremiumRatings
Cautious Hold Rating on Adicet Bio Amid Early-Stage Clinical Developments and Uncertain Outcomes
24d ago
ACET
Adicet Bio: Hold Rating Amid Fair Valuation and Awaited Clinical Data
PremiumRatingsAdicet Bio: Hold Rating Amid Fair Valuation and Awaited Clinical Data
24d ago
ACET
Adicet Bio files $250M mixed securities shelf
Premium
The Fly
Adicet Bio files $250M mixed securities shelf
24d ago
ACET
Adicet Bio reports Q4 EPS (32c), consensus (35c)
Premium
The Fly
Adicet Bio reports Q4 EPS (32c), consensus (35c)
24d ago
ACET
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
ACET
ACHL
Cautious Neutral Recommendation on Adicet Bio Amidst Uncertain Clinical Outcomes and Fair Valuation
PremiumRatings
Cautious Neutral Recommendation on Adicet Bio Amidst Uncertain Clinical Outcomes and Fair Valuation
2M ago
ACET
Adicet Bio granted fast track designation for ADI-001 by FDA
PremiumThe Fly
Adicet Bio granted fast track designation for ADI-001 by FDA
2M ago
ACET
Adicet Bio Advances with Phase 1 Trial of ADI-270
PremiumCompany Announcements
Adicet Bio Advances with Phase 1 Trial of ADI-270
3M ago
8K
ACET
Adicet Bio says 1st patient dosed in Phase1 trial of ADI-270 to treat ccRCC
PremiumThe FlyAdicet Bio says 1st patient dosed in Phase1 trial of ADI-270 to treat ccRCC
3M ago
ACET
Adicet Bio appoints Julie Maltzman, M.D. as Chief Medical Officer
Premium
The Fly
Adicet Bio appoints Julie Maltzman, M.D. as Chief Medical Officer
3M ago
ACET
Adicet Bio Clears Debts with Banc of California
Premium
Company Announcements
Adicet Bio Clears Debts with Banc of California
4M ago
8K
ACET
Adicet Bio Reports Q3 2024 Results and Clinical Progress
PremiumCompany Announcements
Adicet Bio Reports Q3 2024 Results and Clinical Progress
4M ago
ACET
Adicet Bio Advances Cancer and Autoimmune Trials
PremiumCompany Announcements
Adicet Bio Advances Cancer and Autoimmune Trials
4M ago
8K
ACET
Adicet Bio opens enrollment for ADI-270 phase 1 clinical trial in ccRCC
PremiumThe Fly
Adicet Bio opens enrollment for ADI-270 phase 1 clinical trial in ccRCC
4M ago
ACET
Adicet Bio:1st patient dosed in trial evaluating ADI-001 in autoimmune diseases
PremiumThe Fly
Adicet Bio:1st patient dosed in trial evaluating ADI-001 in autoimmune diseases
4M ago
ACET
Adicet Bio reports Q3 EPS (34c), consensus (34c)
PremiumThe FlyAdicet Bio reports Q3 EPS (34c), consensus (34c)
5M ago
ACET
Adicet Bio Advances FDA-Approved Autoimmune Therapy Trials
Premium
Company Announcements
Adicet Bio Advances FDA-Approved Autoimmune Therapy Trials
6M ago
8K
ACET
Adicet Bio announces FDA clearance of ADI-001 IND amendment
Premium
The Fly
Adicet Bio announces FDA clearance of ADI-001 IND amendment
6M ago
ACET

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >